BLPH

Bellerophon Therapeutics, Inc.
BLPH

Overview Fund Activity
Delisted

BLPH was delisted on the 13th of October, 2023.

Back to rankings

26 hedge funds and large institutions have $26.5M invested in Bellerophon Therapeutics, Inc. in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
–
Holders Change %
0%
% of All Funds
0.57%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
3
Increased
7
Reduced
6
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
TI
1
Telemetry Investments
New York
$293K
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$690K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$860K
4
LPL Financial
4
LPL Financial
California
$78K
5
Goldman Sachs
5
Goldman Sachs
New York
$8K

Top Sellers

1
AVM
1
Arch Venture Management
Illinois
$0
2
SM
2
Sabby Management
Florida
$0
3
BCM
3
Bridgeway Capital Management
Texas
$0
4
BlackRock
4
BlackRock
New York
$11K
5
AC
5
Armistice Capital
New York
$1.71M
Name Holding Trade Value Shares
Change 		Shares
Change %
AVM
26
Arch Venture Management
Illinois
– -$631K -64,377 Closed
SM
27
Sabby Management
Florida
– -$202K -20,594 Closed
BCM
28
Bridgeway Capital Management
Texas
– -$103K -10,533 Closed
1
2